Szepi.org

Schizophrenia epidemiology database

Filter Studies

Reference Country Diagnostic system Schizophrenia diagnosis Duration of schizophrenia Setting Mean age Sample size (males/females) Period of diagnosis Type of diagnosis Prevalence
Addington & Addington 2007
Abstract
Comments
Canada DSM-IV broad, 79% narrow First episode inpatients 25 300 (est. 210/est. 90)
(INT: 300)
lifetime abuse/dependence 13.7%

(WAP: 13.70%)
Akvardar et al. 2004
Abstract
Comments
Turkey DSM-IV narrow 16.0 in-/outpatients 39.3 49 (26/23)
(INT: 49)
lifetime abuse, dependence 2.0%
0.0%

(WAP: 2.00%)
Altamura et al. 2003
Abstract
Comments
Italy DSM-III-R broad, 92% narrow 18.8 outpatients 38 81 (55/26)
(INT: 81)
lifetime abuse/dependence 4.9%

(WAP: 4.90%)
Barbee et al. 1989
Abstract
Afghanistan DSM-II / DIS narrow - outpatients - 53 (35/18)
(INT: 53)
lifetime abuse, dependence 35.8% (marijuana)

(WAP: 35.80%)
Barnett et al. 2007
Abstract
Comments
Afghanistan DSM-IV narrow First episode outpatients 0 36 (?/?)
(INT: 36)
lifetime abuse, dependence 16.7%
36.1%

(WAP: 36.10%)
Bersani et al. 2002
Abstract
Comments
Italy DSM-IV narrow 10.3 inpatients 32.4 125 (125/0)
(INT: 125)
current abuse 26.0%

(WAP: 26.00%)
Breakey et al. 1974
Abstract
- Other narrow - inpatients - 46 (28/18)
(INT: 46)
lifetime abuse 45.0% (marijuana)
17.5% (hashish)

(WAP: 45.00%)
Cantor-Graae et al. 2001
Abstract
Comments
Sweden DSM-IV narrow 21.0 in-/outpatients 48 87 (54/33)
(INT: 87)
lifetime abuse 17.2%

(WAP: 17.20%)
Carr et al. 2002
Abstract
Comments
Australia ICD-10 broad 14.7 inpatients 37.8 537 (350/187)
(INT: 537)
lifetime abuse/dependence 30.0%

(WAP: 30.00%)
Cohen & Klein 1970
Abstract
- Other narrow - inpatients - 24 (?/?)
(INT: 24)
lifetime abuse 12.5%

(WAP: 12.50%)
Compton et al. 2004
Abstract
Comments
USA DSM-IV broad, 67% narrow First episode inpatients 20 18 (16/2)
(INT: 18)
lifetime dependence 44.4%

(WAP: 44.40%)
Compton et al. 2005
Abstract
Comments
USA DSM-IV broad, 64% narrow - in-/outpatients 42.9 248 (153/95)
(INT: 248)
lifetime abuse/dependence 6.3%

(WAP: 6.30%)
Compton et al. 2006
Abstract
Comments
Afghanistan DSM-IV broad, 40% narrow First episode inpatients 22.8 25 (19/6)
(INT: 25)
lifetime abuse, dependence 8.0%
40.0%

(WAP: 40.00%)
Cuffel et al. 1993
Abstract
United States in-/outpatients 231 (/)
(INT: 0)
lifetime abuse/dependence 23.0%

(WAP: 23.00%)
De Haan et al. 2007
Abstract
Comments
Netherlands DSM-IV broad, 86% narrow First episode in-/outpatients 20.9 119 (96/23)
(INT: 119)
lifetime abuse/dependence 31.9%

(WAP: 31.90%)
DeQuardo et al. 1994
Abstract
United States inpatients 67 (42/25)
(INT: 0)
lifetime abuse/dependence 28.4%

(WAP: 28.40%)
Dervaux et al. 2001
Abstract
Comments
France DSM-III-R broad, 91% narrow - in-/outpatients 34.7 100 (68/32)
(INT: 100)
lifetime abuse/dependence 27.0%

(WAP: 27.00%)
Deshmukh et al. 2002
Abstract
Comments
Afghanistan DSM-III-R or ?IV narrow - in-/outpatients 31.6 34 (34/0)
(INT: 34)
lifetime abuse, dependence 11.8%
23.5% (both 35.3%)

(WAP: 35.30%)
Dixon et al. 1991
Abstract
United States inpatients 83 (/)
(INT: 0)
lifetime abuse/dependence 31.3%

(WAP: 31.30%)
Dubertret et al. 2006
Abstract
Comments
France DSM-IV narrow 11.3 inpatients 0 205 (139/66)
(INT: 205)
lifetime abuse/dependence 32.2%

(WAP: 32.20%)
Farrelly et al. 2007
Abstract
Comments
Australia DSM-III-R broad, 46% narrow First episode inpatients 21.7 91 (?/?)
(INT: 91)
current abuse/dependence 28.6%

(WAP: 28.60%)
Fowler et al. 1998
Abstract
Comments
Australia DSM-III-R narrow 12.7 outpatients 36.3 194 (141/53)
(INT: 194)
lifetime, current abuse, dependence 7.7%
28.3 (lt)
4.1%
8.8% (c)

(WAP: 7.70%)
Gearon & Bellack 2000
Abstract
Comments
USA DSM-IV narrow 16.2 outpatients 38.3 67 (38/29)
(INT: 67)
lifetime abuse/dependence 41.0%

(WAP: 41.00%)
Gut-Fayand et al. 2001
Abstract
Comments
France DSM-III-R broad, 96% narrow 33.2 in-/outpatients 33.2 50 (32/18)
(INT: 50)
lifetime abuse, dependence 6.0%
8.0%

(WAP: 8.00%)
Hambrecht & Häfner 1996
Abstract
Germany First episode 232 (/)
(INT: 0)
lifetime abuse/dependence 13.0%

(WAP: 13.00%)
Hides et al. 2007
Abstract
Comments
Australia DSM-IV broad appr. 9.4 inpatients 30 142 (102/40)
(INT: 142)
current dependence 53.5%

(WAP: 53.50%)
Holthausen et al. 2002
Abstract
Comments
Netherlands DSM-IV broad First episode inpatients 24.8 118 (87/31)
(INT: 118)
current abuse 48.3%

(WAP: 48.30%)
Kamali et al. 2000
Abstract
Comments
Ireland DSM-IV broad 15.1 inpatients 38.4 102 (68/34)
(INT: 102)
lifetime, current abuse/dependence 16.7%
17.6%

(WAP: 17.60%)
Karam et al. 2002
Abstract
Comments
Lebanon, Israel DSM-III-R narrow - inpatients 34.5 18 (12/6)
(INT: 18)
lifetime abuse 44.4%

(WAP: 44.40%)
Katz et al. 2008
Abstract
Comments
Israel DSM-IV broad - in-/outpatients 0 227 (?/?)
(INT: 227)
lifetime abuse 11.9%

(WAP: 11.90%)
Kavanagh et al. 2004
Abstract
Comments
Australia DSM-III-R narrow - in-/outpatients 0 430 (?/?)
(INT: 430)
lifetime abuse/dependence 26.5%

(WAP: 26.50%)
Kirkpatrick et al. 1996
Abstract
Comments
Afghanistan DSM-IV narrow 11.3 in-/outpatients 34.4 122 (lifetime), 154 (current) (84 (lt), 103 (c)/38 (lt), 51 (c))
(INT: 276)
lifetime, current abuse/dependence 12.3%
1.9%

(WAP: 12.30%)
Kovasznay et al. 1997
Abstract
United States First episode 96 (54/42)
(INT: 0)
lifetime abuse/dependence 30.2%

(WAP: 30.20%)
Magliozzi et al. 1983
Abstract
- DSM-III narrow - inpatients - 57 (57/0)
(INT: 57)
current use 42.0%

(WAP: 42.00%)
Margolese et al. 2004
Abstract
Comments
Canada DSM-IV broad, 62% narrow First episode outpatients 38.8 207 (120/87)
(INT: 207)
current abuse/dependence 8.2%

(WAP: 8.20%)
Modestin et al. 2001
Abstract
Comments
Switzerland ICD-10 narrow 13.2 in-/outpatients 40.6 525 (est. 278/est. 247)
(INT: 525)
lifetime harmful use/dependence 12.0%

(WAP: 12.00%)
Moilanen et al. 2003
Abstract
Comments
Finland DSM-III-R narrow 9.3 in-/outpatients 0 96 (63/33)
(INT: 96)
lifetime abuse/dependence 0.0%

(WAP: 0.00%)
Mueser et al. 2000
Abstract
Comments
USA DSM-III-R broad, 51% narrow - inpatients 38.8 173 (154/19)
(INT: 173)
lifetime abuse/dependence 27.2%

(WAP: 27.20%)
Mueser et al. 1990
Abstract
United States inpatients 149 (95/54)
(INT: 0)
lifetime abuse/dependence 42.0%

(WAP: 42.00%)
Mueser et al. 1992
Abstract
United States inpatients 159 (/)
(INT: 0)
lifetime abuse/dependence 15.7%

(WAP: 15.70%)
Negrete et al. 1986
Abstract
- ICD-9 narrow - outpatients - 137 (82/55)
(INT: 137)
lifetime, current use 55.5%
18.2%

(WAP: 55.50%)
Peralta & Cuesta 1992
Abstract
Spain inpatients 95 (63/32)
(INT: 0)
current abuse/dependence 24.0%

(WAP: 24.00%)
Rabinowitz et al. 1998
Abstract
Comments
USA DSM-III-R not reported First episode inpatients 0 224 (146/78)
(INT: 224)
lifetime abuse/dependence 31.3%

(WAP: 31.30%)
Röder-Wanner & Priebe 1998
Abstract
Germany First episode 90 (30/60)
(INT: 0)
lifetime abuse/dependence 18.9%

(WAP: 18.90%)
Siris et al. 1988
Abstract
- RDC, SADS broad - outpatients - 46 (24/22)
(INT: 46)
lifetime abuse 35.0% (marijuana)

(WAP: 35.00%)
Verdoux et al. 2001
Abstract
Comments
France DSM-IV broad, 44% narrow First episode inpatients 31 27 (15/12)
(INT: 27)
lifetime abuse/dependence 18.5%

(WAP: 18.50%)
Wade et al. 2005
Abstract
Comments
Australia DSM-III-R not reported First episode inpatients 21.3 93 (68/25)
(INT: 93)
lifetime abuse/dependence 65.6%

(WAP: 65.60%)
Wobrock et al. 2007
Abstract
Comments
Germany ICD-10 not reported First episode inpatients 25.7 68 (est. 45/est. 23)
(INT: 68)
lifetime harmful use 45.6%

(WAP: 45.60%)
Xafenias et al. 2008
Abstract
Comments
Greece DSM-IV not reported - inpatients 0 105 (?/?)
(INT: 105)
current abuse/dependence 8.6%

(WAP: 8.60%)
Ziedonis & Trudeau 1997
Abstract
Comments
USA DSM-III-R broad, 64% narrow - outpatients 44 497 (253/244)
(INT: 497)
current abuse 14.3%

(WAP: 14.30%)
Number of studies: 50 · Weighted average prevalence: 22.84% · Median: 27.10% · Range: 0.00% – 65.60% | Show meta-analysis

References

  • First reference
  • Second reference
  • Third reference